Bath Savings Trust Co reduced its stake in Walgreens Boots Alliance Inc (NASDAQ:WBA) by 3.3% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 50,341 shares of the pharmacy operator’s stock after selling 1,710 shares during the period. Bath Savings Trust Co’s holdings in Walgreens Boots Alliance were worth $3,888,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors also recently made changes to their positions in the stock. Hefty Wealth Partners grew its stake in shares of Walgreens Boots Alliance by 5,097.8% during the third quarter. Hefty Wealth Partners now owns 9,616 shares of the pharmacy operator’s stock valued at $743,000 after acquiring an additional 9,431 shares in the last quarter. Perpetual Ltd grew its stake in shares of Walgreens Boots Alliance by 22.4% during the second quarter. Perpetual Ltd now owns 6,552 shares of the pharmacy operator’s stock valued at $513,000 after acquiring an additional 1,200 shares in the last quarter. MPS Loria Financial Planners LLC acquired a new stake in shares of Walgreens Boots Alliance during the second quarter valued at about $457,000. Davidson Kempner Capital Management LP acquired a new stake in shares of Walgreens Boots Alliance during the second quarter valued at about $13,701,000. Finally, Burgundy Asset Management Ltd. grew its stake in shares of Walgreens Boots Alliance by 5.0% during the second quarter. Burgundy Asset Management Ltd. now owns 5,441,307 shares of the pharmacy operator’s stock valued at $426,109,000 after acquiring an additional 260,756 shares in the last quarter. Hedge funds and other institutional investors own 60.24% of the company’s stock.

WBA has been the subject of several recent analyst reports. UBS restated a “buy” rating and set a $96.00 target price (down from $97.00) on shares of Walgreens Boots Alliance in a research note on Wednesday, August 23rd. Loop Capital initiated coverage on Walgreens Boots Alliance in a research note on Thursday, August 24th. They set a “buy” rating and a $95.00 target price for the company. BidaskClub upgraded Walgreens Boots Alliance from a “sell” rating to a “hold” rating in a research note on Wednesday, August 30th. Jefferies Group restated a “buy” rating and set a $95.00 target price on shares of Walgreens Boots Alliance in a research note on Thursday, September 7th. Finally, Needham & Company LLC restated a “buy” rating and set a $94.00 target price on shares of Walgreens Boots Alliance in a research note on Sunday, September 10th. One equities research analyst has rated the stock with a sell rating, nine have given a hold rating and fourteen have assigned a buy rating to the stock. The company has a consensus rating of “Buy” and a consensus target price of $86.47.

Walgreens Boots Alliance Inc (NASDAQ WBA) opened at $71.05 on Thursday. The company has a market capitalization of $69,503.16, a PE ratio of 13.76, a P/E/G ratio of 1.25 and a beta of 1.22. Walgreens Boots Alliance Inc has a 52 week low of $63.82 and a 52 week high of $88.00. The company has a quick ratio of 0.59, a current ratio of 1.07 and a debt-to-equity ratio of 0.45.

Walgreens Boots Alliance (NASDAQ:WBA) last posted its quarterly earnings results on Wednesday, October 25th. The pharmacy operator reported $1.31 EPS for the quarter, topping the Zacks’ consensus estimate of $1.21 by $0.10. The business had revenue of $30.15 billion during the quarter, compared to the consensus estimate of $29.93 billion. Walgreens Boots Alliance had a return on equity of 18.36% and a net margin of 3.45%. The company’s revenue for the quarter was up 5.3% compared to the same quarter last year. During the same period last year, the firm earned $1.07 earnings per share. analysts anticipate that Walgreens Boots Alliance Inc will post 5.55 EPS for the current fiscal year.

The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 12th. Shareholders of record on Monday, November 13th will be issued a $0.40 dividend. The ex-dividend date of this dividend is Friday, November 10th. This represents a $1.60 dividend on an annualized basis and a yield of 2.25%. Walgreens Boots Alliance’s dividend payout ratio is currently 42.33%.

Walgreens Boots Alliance announced that its board has authorized a share buyback plan on Wednesday, October 25th that allows the company to buyback $1.00 billion in outstanding shares. This buyback authorization allows the pharmacy operator to reacquire shares of its stock through open market purchases. Shares buyback plans are usually an indication that the company’s management believes its stock is undervalued.

In other news, Director William C. Foote sold 2,736 shares of Walgreens Boots Alliance stock in a transaction that occurred on Thursday, November 2nd. The stock was sold at an average price of $67.37, for a total transaction of $184,324.32. Following the sale, the director now owns 16,415 shares of the company’s stock, valued at $1,105,878.55. The transaction was disclosed in a filing with the SEC, which is accessible through this link. Also, Director John Anthony Lederer purchased 20,000 shares of the business’s stock in a transaction dated Thursday, October 26th. The shares were acquired at an average cost of $67.00 per share, for a total transaction of $1,340,000.00. Following the acquisition, the director now owns 50,000 shares of the company’s stock, valued at approximately $3,350,000. The disclosure for this purchase can be found here. Company insiders own 14.80% of the company’s stock.

WARNING: This piece of content was originally reported by Daily Political and is the sole property of of Daily Political. If you are reading this piece of content on another site, it was illegally stolen and republished in violation of US and international copyright legislation. The correct version of this piece of content can be read at https://www.dailypolitical.com/2017/12/07/bath-savings-trust-co-sells-1710-shares-of-walgreens-boots-alliance-inc-wba.html.

Walgreens Boots Alliance Profile

Walgreens Boots Alliance, Inc (Walgreens Boots Alliance) is a holding company. The Company is a global pharmacy-led, health and wellbeing enterprise. Walgreens Boots Alliance operates through three divisions, including Retail Pharmacy USA, Retail Pharmacy International and Pharmaceutical Wholesale. The Company’s products are marketed under a number of brands, which include No7, the Botanics range, Almus (generic medicines), Boots Pharmaceuticals and Soap & Glory (bathing and beauty brand).

Institutional Ownership by Quarter for Walgreens Boots Alliance (NASDAQ:WBA)

Receive News & Ratings for Walgreens Boots Alliance Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Walgreens Boots Alliance Inc and related companies with MarketBeat.com's FREE daily email newsletter.